Company’s unique technologies have been granted five new patents in
2013 alone
COPPELL, Texas--(BUSINESS WIRE)--Aug. 14, 2013--
Mannatech,
Incorporated (NASDAQ: MTEX),
the leading innovator and provider of glyconutrient technology and
naturally-sourced supplements based on Real
Food Technology® solutions, and founders of
the Mission 5 MillionSM social entrepreneurial movement,
announced the issuance of five new patents to date in 2013 for
technologies related to its product portfolio. In total, Mannatech now
holds 90 patents worldwide.
In 2013, four patents for the technology related to Mannatech’s
Ambrotose AO® formulation have been issued in various
countries (two in Mexico, one in Canada and one in Taiwan), and one
patent has been issued in Australia for the technology related to its
GI-ProBalance® formulation. Ambrotose
AO capsules combine a blend of plant extracts and antioxidant
compounds that are clinically proven to provide over 2 ½ times more
antioxidant protection than five servings of fruits and vegetables. GI-ProBalance
slimsticks are Mannatech’s solution for superior probiotic
health, providing six different strains of probiotics and two different
prebiotics for a wide variety of health support.
“Mannatech’s patent portfolio, which the company had the foresight to
start developing in the mid-1990s, has now yielded 90 patents issued
globally,” said Dr. Robert A. Sinnott, CEO and Chief Science Officer of
Mannatech. “Our chain of systematic research and intellectual property
development has continued without pause throughout the entire history of
the company. This gives us much more protected space in the rapidly
growing wellness industry than almost all of our competitors have, or
ever will obtain. This is a huge asset in an industry that has
significantly raised the bar on validation of health supplements.”
Individuals interested in Mannatech’s products, or exploring its social
entrepreneurial efforts to help fight global malnutrition, can learn
more at Mannatech.com.
About Mannatech
Mannatech, Incorporated, develops high-quality health, weight and
fitness, and skin care products that are based on the solid foundation
of nutritional science and development standards. Mannatech is dedicated
to its platform of Social Entrepreneurship based on the foundation of
promoting, aiding and optimizing nutrition where it is needed most
around the world. Mannatech’s proprietary products are available through
independent sales Associates around the globe including the United
States, Canada, South Africa, Australia, New Zealand, Austria, Denmark,
Germany, Norway, Sweden, the Netherlands, the United Kingdom, Japan,
Taiwan, Singapore, Estonia, Finland, the Republic of Ireland, Czech
Republic, the Republic of Korea, Mexico, Namibia, Hong Kong and Ukraine.
For more information, visit Mannatech.com.
Please note: This release contains “forward-looking statements”
within the meaning of Section 27A of the Securities Act of 1933, as
amended, Section 21E of the Securities Exchange Act of 1934, as amended,
and the Private Securities Litigation Reform Act of 1995. These
forward-looking statements generally can be identified by use of phrases
or terminology such as “believe,” “intend” or other similar words or the
negative of such terminology. Similarly, descriptions of Mannatech’s
objectives, strategies, plans, goals or targets contained herein are
also considered forward-looking statements. Mannatech believes this
release should be read in conjunction with all of its filings with the
United States Securities and Exchange Commission and cautions its
readers that these forward-looking statements are subject to certain
events, risks, uncertainties and other factors. Some of these factors
include, among others, Mannatech’s inability to attract and retain
Associates and Members, increases in competition, litigation, regulatory
changes and its planned growth into new international markets. Although
Mannatech believes that the expectations, statements and assumptions
reflected in these forward-looking statements are reasonable, it
cautions readers to always consider all of the risk factors and any
other cautionary statements carefully in evaluating each forward-looking
statement in this release, as well as those set forth in its latest
Annual Report on Form 10-K and Quarterly Report on Form 10-Q, and other
filings filed with the United States Securities and Exchange Commission,
including its current reports on Form 8-K. All of the forward-looking
statements contained herein speak only as of the date of this release.
Source: Mannatech, Incorporated
Mannatech, Incorporated
Brett Duncan, 972-471-7367
bduncan@mannatech.com